New York State Common Retirement Fund Kymera Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 15,649 shares of KYMR stock, worth $638,792. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,649
Previous 20,849
24.94%
Holding current value
$638,792
Previous $622,000
19.13%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding KYMR
# of Institutions
184Shares Held
64.4MCall Options Held
50.6KPut Options Held
81.7K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$271 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$245 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$211 Million7.77% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$200 Million28.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.75MShares$194 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.23B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...